BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: d'Ettorre G, Ceccarelli G, Pavone P, Vittozzi P, De Girolamo G, Schietroma I, Serafino S, Giustini N, Vullo V. What happens to cardiovascular system behind the undetectable level of HIV viremia? AIDS Res Ther 2016;13:21. [PMID: 27127532 DOI: 10.1186/s12981-016-0105-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Bellinati PQ, Alfieri DF, Flauzino T, Junior PFG, Rossi DJ, Breganó JW, Simão ANC, de Almeida ERD, Lozovoy MAB, Reiche EMV. Association of Lower Adiponectin Plasma Levels, Increased Age and Smoking with Subclinical Atherosclerosis in Patients with HIV-1 Infection. Curr HIV Res 2020;18:292-306. [PMID: 32516102 DOI: 10.2174/1570162X18666200609114741] [Reference Citation Analysis]
2 Camps-Vilaró A, Pérez-Fernández S, Subirana I, Teira R, Estrada V, Domingo P, Dégano IR, Marrugat J. Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population. J Pers Med 2021;11:1085. [PMID: 34834438 DOI: 10.3390/jpm11111085] [Reference Citation Analysis]
3 Graham SM, Chen J, Le J, Ling M, Chung DW, Liles WC, López JA. Von Willebrand Factor Adhesive Activity and ADAMTS13 Protease Activity in HIV-1-Infected Men. Int J Med Sci 2019;16:276-84. [PMID: 30745808 DOI: 10.7150/ijms.28110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Lawal SK, Olojede SO, Dare A, Faborode OS, Naidu ECS, Rennie CO, Azu OO. Silver Nanoparticles Conjugate Attenuates Highly Active Antiretroviral Therapy-Induced Hippocampal Nissl Substance and Cognitive Deficits in Diabetic Rats. J Diabetes Res 2021;2021:2118538. [PMID: 34840987 DOI: 10.1155/2021/2118538] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Crespo-Bermejo C, de Arellano ER, Lara-Aguilar V, Valle-Millares D, Gómez-Lus ML, Madrid R, Martín-Carbonero L, Briz V. Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status. Virulence 2021;12:2919-31. [PMID: 34874239 DOI: 10.1080/21505594.2021.2004743] [Reference Citation Analysis]
6 Beraldo RA, Santos APD, Guimarães MP, Vassimon HS, Paula FJA, Machado DRL, Foss-Freitas MC, Navarro AM. Body fat redistribution and changes in lipid and glucose metabolism in people living with HIV/AIDS. Rev Bras Epidemiol 2017;20:526-36. [PMID: 29160443 DOI: 10.1590/1980-5497201700030014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
7 Romeo R, Iannazzo D, Veltri L, Gabriele B, Macchi B, Frezza C, Marino-Merlo F, Giofrè SV. Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors. Molecules 2019;24:E1718. [PMID: 31052607 DOI: 10.3390/molecules24091718] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
8 Bertrand L, Dygert L, Toborek M. Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity. Sci Rep 2016;6:39738. [PMID: 28008980 DOI: 10.1038/srep39738] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
9 Bertrand L, Méroth F, Tournebize M, Leda AR, Sun E, Toborek M. Targeting the HIV-infected brain to improve ischemic stroke outcome. Nat Commun 2019;10:2009. [PMID: 31043599 DOI: 10.1038/s41467-019-10046-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
10 Spitsin S, Tebas P, Barrett JS, Pappa V, Kim D, Taylor D, Evans DL, Douglas SD. Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adults. JCI Insight 2017;2:95893. [PMID: 28978797 DOI: 10.1172/jci.insight.95893] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
11 Bagella P, Squillace N, Ricci E, Gulminetti R, De Socio GV, Taramasso L, Pellicanò G, Menzaghi B, Celesia BM, Dentone C, Orofino G, Bonfanti P, Madeddu G. Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project. Infect Drug Resist 2019;12:1385-91. [PMID: 31213857 DOI: 10.2147/IDR.S203813] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Karim B, Wijaya IP, Rahmaniyah R, Ariyanto I, Waters S, Estiasari R, Price P. Factors affecting affect cardiovascular health in Indonesian HIV patients beginning ART. AIDS Res Ther 2017;14:52. [PMID: 28859681 DOI: 10.1186/s12981-017-0180-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
13 Jindal AK, Bhattad S, Suri D, Singhal M, Gupta A, Singh P. Moyamoya Syndrome in a Child With HIV-1 Infection. Pediatr Infect Dis J 2018;37:e166-7. [PMID: 29189606 DOI: 10.1097/INF.0000000000001841] [Reference Citation Analysis]
14 Adzhubei AA, Anashkina AA, Tkachev YV, Kravatsky YV, Pushkarsky T, Kulkarni A, Makarov AA, Bukrinsky MI. Modelling interaction between HIV-1 Nef and calnexin. AIDS 2018;32:2103-11. [PMID: 30005006 DOI: 10.1097/QAD.0000000000001951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Pinto DSM, da Silva MJLV. Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection. Curr Cardiol Rev 2018;14:25-41. [PMID: 29189172 DOI: 10.2174/1573403X13666171129170046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
16 Di Carlo D, Falasca F, Palermo E, Mezzaroma I, Fimiani C, Siccardi G, Celani L, Di Campli FM, d'Ettorre G, Antonelli G, Turriziani O. Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life Setting. AIDS Res Hum Retroviruses 2021;37:478-85. [PMID: 33487130 DOI: 10.1089/AID.2020.0196] [Reference Citation Analysis]
17 Morillo-Verdugo R, Robustillo-Cortés MLA, Martín-Conde MT, Callejón-Callejón G, Cid-Silva P, Moriel-Sánchez C, Tortajada-Goitia B, Almeida-González CV. Effect of a Structured Pharmaceutical Care Intervention Versus Usual Care on Cardiovascular Risk in HIV Patients on Antiretroviral Therapy: INFAMERICA Study. Ann Pharmacother 2018;52:1098-108. [PMID: 29808711 DOI: 10.1177/1060028018778045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
18 Grand M, Bia D, Diaz A. Cardiovascular Risk Assessment in People Living With HIV: A Systematic Review and Meta-Analysis of Real-Life Data. Curr HIV Res 2020;18:5-18. [PMID: 31830884 DOI: 10.2174/1570162X17666191212091618] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
19 Knudsen AD, Krebs-Demmer L, Bjørge NID, Elming MB, Gelpi M, Sigvardsen PE, Lebech AM, Fuchs A, Kühl JT, Køber L, Lundgren J, Nordestgaard BG, Kofoed KF, Nielsen SD. Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir. J Infect Dis 2020;222:54-61. [PMID: 32027374 DOI: 10.1093/infdis/jiaa057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Leong YA, Atnerkar A, Yu D. Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle Sanctuary. Front Immunol 2017;8:622. [PMID: 28620380 DOI: 10.3389/fimmu.2017.00622] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
21 Teigler JE, Leyre L, Chomont N, Slike B, Jian N, Eller MA, Phanuphak N, Kroon E, Pinyakorn S, Eller LA, Robb ML, Ananworanich J, Michael NL, Streeck H, Krebs SJ; RV254/RV217 study groups. Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir size. JCI Insight 2018;3:98420. [PMID: 29769442 DOI: 10.1172/jci.insight.98420] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
22 Falasca F, Di Carlo D, De Vito C, Bon I, d'Ettorre G, Fantauzzi A, Mezzaroma I, Fimiani C, Re MC, Vullo V, Antonelli G, Turriziani O. Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns. BMC Infect Dis 2017;17:581. [PMID: 28830393 DOI: 10.1186/s12879-017-2676-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
23 Beraldo RA, Meliscki GC, Silva BR, Navarro AM, Bollela VR, Schmidt A, Foss-Freitas MC. Anthropometric measures of central adiposity are highly concordant with predictors of cardiovascular disease risk in HIV patients. Am J Clin Nutr 2018;107:883-93. [PMID: 29868914 DOI: 10.1093/ajcn/nqy049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]